Business Wire06.16.21
SANUWAVE Health Inc., focused on the development and commercialization of an advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, has announced its rebranding. The new brand reflects the evolution of SANUWAVE’s solutions addressing the entire wound care pathway through its portfolio of noninvasive and biological response therapeutics that help expedite the wound healing process at the cellular level, resulting in less time and resources spent on more costly treatments.
The combination of SANUWAVE’s dermaPACE System and the UltraMIST System—acquired from Celularity Inc. in 2020—is the basis for its “Energy First” protocol for wound healing. Additionally, premium licensing of two important biologics from Cellularity— BIOVANCE Human Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix—add to a portfolio of solutions that improve clinical outcomes across the continuum of wound care.
“In light of our growth and expansion, we are excited to launch SANUWAVE’s new brand, featuring our complete line of healing systems and biologics offerings,” said SANUWAVE CEO and Board Chairman Kevin A. Richardson II. “Our Energy First approach enables us to provide effective treatment options for patients requiring advanced wound care, closure, and healing. We invite everyone to visit our new website and explore what today’s SANUWAVE has to offer.”
The combination of SANUWAVE’s dermaPACE System and the UltraMIST System—acquired from Celularity Inc. in 2020—is the basis for its “Energy First” protocol for wound healing. Additionally, premium licensing of two important biologics from Cellularity— BIOVANCE Human Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix—add to a portfolio of solutions that improve clinical outcomes across the continuum of wound care.
“In light of our growth and expansion, we are excited to launch SANUWAVE’s new brand, featuring our complete line of healing systems and biologics offerings,” said SANUWAVE CEO and Board Chairman Kevin A. Richardson II. “Our Energy First approach enables us to provide effective treatment options for patients requiring advanced wound care, closure, and healing. We invite everyone to visit our new website and explore what today’s SANUWAVE has to offer.”